We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

123 hedge funds and large institutions have $807M invested in Intersect ENT, Inc in 2021 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more capital invested

Capital invested by funds: $495M → $807M (+$312M)

59% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 29

15% more funds holding

Funds holding: 107123 (+16)

13% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 30

86% less call options, than puts

Call options by funds: $262K | Put options by funds: $1.91M

Holders
123
Holders Change
+16
Holders Change %
+14.95%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
46
Increased
34
Reduced
30
Closed
29
Calls
$262K
Puts
$1.91M
Net Calls
-$1.65M
Net Calls Change
-$884K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$70.6M -$8.96M -362,503 -12%
MF
2
Magnetar Financial
Illinois
$69.6M +$63.2M +2,557,763 New
VI
3
Versor Investments
New York
$61.4M +$55.8M +2,258,108 New
FLAM
4
First Light Asset Management
Minnesota
$58.1M -$1.83M -74,147 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$48.5M +$1.09M +43,954 +3%
Millennium Management
6
Millennium Management
New York
$42.9M +$35.7M +1,442,615 +1,084%
Artisan Partners
7
Artisan Partners
Wisconsin
$39.6M -$74.7M -3,019,917 -67%
AAM
8
Alpine Associates Management
Florida
$37.9M +$34.4M +1,393,000 New
RSCM
9
Rock Springs Capital Management
Maryland
$33.2M
State Street
10
State Street
Massachusetts
$27.7M +$307K +12,422 +1%
Morgan Stanley
11
Morgan Stanley
New York
$19.7M +$13.8M +557,051 +335%
Neuberger Berman Group
12
Neuberger Berman Group
New York
$16.1M -$8.95M -361,833 -37%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$15.4M +$297K +12,023 +2%
AllianceBernstein
14
AllianceBernstein
Tennessee
$13.8M +$11.6M +468,238 +1,194%
NI
15
Nuance Investments
Missouri
$12.7M +$11.6M +468,554 New
OPU
16
Omni Partners US
California
$12.4M +$11.3M +456,396 New
Goldman Sachs
17
Goldman Sachs
New York
$11.9M +$6.76M +273,347 +166%
N
18
Nuveen
North Carolina
$10M -$6.32M -255,433 -41%
Northern Trust
19
Northern Trust
Illinois
$10M -$201K -8,146 -2%
AA
20
AQR Arbitrage
Connecticut
$9.85M +$8.95M +361,999 New
JP Morgan Chase
21
JP Morgan Chase
New York
$9.48M +$7.05M +285,038 +449%
Citigroup
22
Citigroup
New York
$9.47M +$8.27M +334,492 +2,450%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$9.16M +$3.27M +132,300 +65%
CCM
24
Crabel Capital Management
California
$7.44M +$6.76M +273,423 New
AIMCA
25
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$7.2M +$6.54M +264,676 New

XENT Hedge Fund Activity: Q3 2021 in Review

123 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2021, worth a combined $807M — up 63% from $495M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new XENT positions and 29 closed out — a net gain of 17 holders — while 34 added to existing stakes and 30 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $63.2M. The largest seller was Artisan Partners, cutting an estimated $74.7M.

  • 123 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2021, up from 107 in Q2 2021.
  • Funds reported $807M of Intersect ENT, Inc stock for Q3 2021, up 63% quarter-over-quarter.
  • 46 funds opened new Intersect ENT, Inc positions in Q3 2021 and 29 closed out, a net change of +17 holders.
  • The largest Intersect ENT, Inc buyer in Q3 2021 was Magnetar Financial, an estimated $63.2M added.
  • The largest Intersect ENT, Inc seller in Q3 2021 was Artisan Partners, an estimated $74.7M sold.

Based on aggregated 13F filings for Q3 2021.